| Primary |
|
| Malaise |
50.0% |
| Medication Error |
50.0% |
|
| Secondary |
| Product Used For Unknown Indication |
18.0% |
| Drug Dependence |
16.5% |
| Crohn's Disease |
15.9% |
| Foetal Exposure During Pregnancy |
10.1% |
| Drug Exposure In Utero |
7.0% |
| Pregnancy |
7.0% |
| Nicotine Dependence |
3.2% |
| Nausea |
2.9% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Vitamin Supplementation |
2.3% |
| Epilepsy |
2.0% |
| Hypertension |
2.0% |
| Anxiety |
1.7% |
| Medical Diet |
1.7% |
| Tobacco User |
1.4% |
| Transplant |
1.4% |
| Depression |
1.2% |
| Insomnia |
1.2% |
| Maternal Exposure Timing Unspecified |
1.2% |
| Constipation |
0.9% |
|
| Premature Baby |
19.7% |
| Muscular Weakness |
13.1% |
| Foetal Exposure During Pregnancy |
11.5% |
| Low Birth Weight Baby |
9.8% |
| Maternal Drugs Affecting Foetus |
6.6% |
| Premature Labour |
4.9% |
| Placenta Praevia |
3.3% |
| Respiratory Rate Increased |
3.3% |
| Speech Disorder Developmental |
3.3% |
| Torticollis |
3.3% |
| Tremor |
3.3% |
| Twin Pregnancy |
3.3% |
| Umbilical Cord Abnormality |
3.3% |
| Abortion Spontaneous |
1.6% |
| Cleft Palate |
1.6% |
| Drug Exposure During Pregnancy |
1.6% |
| Exposure During Breast Feeding |
1.6% |
| Gastrointestinal Motility Disorder |
1.6% |
| Hypertension |
1.6% |
| Hypoglycaemia Neonatal |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.8% |
| Depression |
15.0% |
| Anxiety |
7.4% |
| Foetal Exposure During Pregnancy |
6.2% |
| Crohn's Disease |
6.1% |
| Pregnancy |
5.8% |
| Contraception |
4.7% |
| Epilepsy |
4.1% |
| Drug Use For Unknown Indication |
3.9% |
| Vitamin Supplementation |
3.2% |
| Pain |
3.0% |
| Rheumatoid Arthritis |
2.7% |
| Asthma |
2.6% |
| Multiple Sclerosis |
2.4% |
| Nausea |
2.2% |
| Migraine |
1.9% |
| Convulsion |
1.6% |
| Headache |
1.5% |
| Drug Dependence |
1.5% |
| Supplementation Therapy |
1.5% |
|
| Ventricular Septal Defect |
21.4% |
| Drug Exposure During Pregnancy |
13.9% |
| Pregnancy |
9.3% |
| Vomiting |
6.5% |
| Premature Baby |
5.9% |
| Maternal Exposure During Pregnancy |
4.4% |
| Talipes |
3.9% |
| Device Expulsion |
3.7% |
| Abortion Spontaneous |
3.5% |
| Vaginal Haemorrhage |
3.5% |
| Premature Labour |
3.2% |
| Weight Gain Poor |
3.1% |
| Maternal Exposure Timing Unspecified |
2.9% |
| Exposure During Pregnancy |
2.5% |
| Tricuspid Valve Incompetence |
2.3% |
| Nausea |
2.1% |
| Pulmonary Embolism |
2.1% |
| Weight Decreased |
2.1% |
| Patent Ductus Arteriosus |
2.0% |
| Pain |
1.8% |
|
| Interacting |
| Contraception |
50.0% |
| Vitamin Supplementation |
50.0% |
|
|
